Navidea Biopharmaceuticals, Inc. (NAVB) Social Stream



Navidea Biopharmaceuticals, Inc. (NAVB): $0.04

0.00 (-1.66%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add NAVB to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#386 of 493

in industry

NAVIDEA BIOPHARMACEUTICALS INC (NAVB) Price Targets From Analysts

Use the tables below to see what analysts covering NAVIDEA BIOPHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-05-14 1 $5 $5 $5 $0.078 6310.26%
2021-11-11 2 $8 $5 $6.5 $0.078 8233.33%

Price Target Last Issued May 14, 2021

500 - Internal server error

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential

NAVB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NAVB as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, NAVIDEA BIOPHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 199.62% of them.
  • NAVIDEA BIOPHARMACEUTICALS INC's number of analysts covering the stock is greater than 3.03% of all US stocks.
  • In the context of Healthcare stocks, NAVIDEA BIOPHARMACEUTICALS INC's average analyst price target is higher than 17.29% of them.
  • In terms of how NAVIDEA BIOPHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 69.11% of that group.

In the Pharmaceutical Products industry, OCX, TRIB, and ABIO are the three stocks most similar to NAVIDEA BIOPHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.

Is NAVB a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!